CompaniesBlueSky Immunotherapies

BlueSky Immunotherapies

active
Vienna, Austria
Founded 2014
Website
About

Virotherapy for Cancer

Areas of Focus

Categories

Virus TechnologyAustria
Clinical Trials (4)
View all

Total Trials

4

As Lead Sponsor

4

As Collaborator

0

Total Enrollment

85

By Phase

PHASE1: 3

By Status

RECRUITING: 2COMPLETED: 2
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
NCT04490512
NCT04528407
NCT05829629
NCT06589609
Hover over trial bars to see details

Recent Trials

NCT06589609Lead Sponsor
Phase 1 Clinical Trial of FluBHPVE6E7 Immunotherapy for HPV16-Associated Oropharyngeal Cancer
PHASE1Recruiting
12 participants
Started: Aug 23, 2024 · Completed: Nov 30, 2029
NCT05829629Lead Sponsor
Phase 1 Dose-escalation Study of FluBHPVE6E7 in HPV16-infected Women
PHASE1Recruiting
20 participants
Started: Sep 12, 2023 · Completed: Nov 30, 2025
NCT04528407Lead Sponsor
BS-FU01 Follow-Up Study of FluBHPVE6E7 Study Subjects
N/ACompleted
25 participants
Started: Apr 9, 2021 · Completed: Jan 31, 2025
NCT04490512Lead Sponsor
Study of FluBHPVE6E7 in HPV-16 Infected Women
PHASE1Completed
28 participants
Started: Dec 9, 2020 · Completed: Jun 6, 2023
Locations (1)
Headquarters
Vienna, Austria
Map

Loading map...